Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA
A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.
Laboratory tests using preparations of Ebola virus and other hemorrhagic fever viruses showed that the system has the sensitivity and specificity needed to provide a viable clinical assay. The team reported their results in a paper published September 25 in Nature Scientific Reports.
An outbreak of Ebola virus in West Africa has killed more than 11,000 people since 2014, with new cases occurring recently in Guinea and Sierra Leone. The current gold standard for Ebola virus detection relies on a method called polymerase chain reaction (PCR) to amplify the virus’s genetic material for detection. Because PCR works on DNA molecules and Ebola is an RNA virus, the reverse transcriptase enzyme is used to make DNA copies of the viral RNA prior to PCR amplification and detection.
“Compared to our system, PCR detection is more complex and requires a laboratory setting,” said senior author Holger Schmidt, the Kapany Professor of Optoelectronics at UC Santa Cruz. “We’re detecting the nucleic acids directly, and we achieve a comparable limit of detection to PCR and excellent specificity.”
In laboratory tests, the system provided sensitive detection of Ebola virus while giving no positive counts in tests with two related viruses, Sudan virus and Marburg virus. Testing with different concentrations of Ebola virus demonstrated accurate quantification of the virus over six orders of magnitude. Adding a “preconcentration” step during sample processing on the microfluidic chip extended the limit of detection well beyond that achieved by other chip-based approaches, covering a range comparable to PCR analysis.
“The measurements were taken at clinical concentrations covering the entire range of what would be seen in an infected person,” Schmidt said.
Schmidt’s lab at UC Santa Cruz worked with researchers at Brigham Young University and UC Berkeley to develop the system. Virologists at Texas Biomedical Research Institute in San Antonio prepared the viral samples for testing.
The system combines two small chips, a microfluidic chip for sample preparation and an optofluidic chip for optical detection. For over a decade, Schmidt and his collaborators have been developing optofluidic chip technology for optical analysis of single molecules as they pass through a tiny fluid-filled channel on the chip. The microfluidic chip for sample processing can be integrated as a second layer next to or on top of the optofluidic chip.
Schmidt’s lab designed and built the microfluidic chip in collaboration with coauthor Richard Mathies at UC Berkeley who pioneered this technology. It is made of a silicon-based polymer, polydimethylsiloxane (PDMS), and has microvalves and fluidic channels to transport the sample between nodes for various sample preparation steps. The targeted molecules–in this case, Ebola virus RNA–are isolated by binding to a matching sequence of synthetic DNA (called an oligonucleotide) attached to magnetic microbeads. The microbeads are collected with a magnet, nontarget biomolecules are washed off, and the bound targets are then released by heating, labeled with fluorescent markers, and transferred to the optofluidic chip for optical detection.
Schmidt noted that the team has not yet been able to test the system starting with raw blood samples. That will require additional sample preparation steps, and it will also have to be done in a biosafety level 4 facility.
The Latest on: Ebola detection
via Google News
The Latest on: Ebola detection
- Africa Against Ebola: A Private Sector and Partners Forumon November 29, 2019 at 9:56 pm
Strengthen the local health systems including placing of surveillance platform, diagnostic capacities for early detection, rapid response and containment of future outbreaks at the source. All these ...
- Democratic Republic of the Congo – Ebola Outbreak Fact Sheet #2, Fiscal Year (...on November 29, 2019 at 3:52 pm
The U.S. Government (USG) Disaster Assistance Response Team (DART), the U.S. Centers for Disease Control and Prevention (CDC), and other response actors continue to emphasize that the ongoing Ebola ...
- Liberia Adapts WHO/AFRO’s 3rd Edition of the Integrated Diseases Surveillance and Response (IDSR) Technical Guidelineson November 29, 2019 at 8:21 am
The unprecedented 2014- 2015 Ebola epidemic affected approximately 10,675 Liberians and had a devastating ... with the objective of strengthening national and international capacities for the ...
- Ridgeback Biotherapeutics LP announces publication of mAb114 results in the New England Journal of Medicineon November 28, 2019 at 4:06 pm
Professor Jean-Jacques Muyembe, director general of INRB and one of the scientists involved in the original detection of the Ebola virus in 1976, played a key role in discovering mAb114. About ...
- Johnson & Johnson launches Ebola vaccineon November 25, 2019 at 8:53 pm
Johnson & Johnson launched a new vaccine for Ebola with unknown long-term effects in Congo and plan on injecting approximately 500,000 people in the next 10 months. The vaccine requires two shots to ...
- UN: Spike in violence may jeopardize ending Ebola in Congoon November 22, 2019 at 2:12 am
Ryan says WHO understands all the chains of Ebola transmission in this outbreak except one ... of nuclear engineers who died when a new weapon exploded at the navy’s testing range. Speaking in remarks ...
- Ebola Vaccine Licensure Is Underway With The Help Of UF Researcherson November 18, 2019 at 9:57 am
“It’s pretty much unprecedented to conduct a vaccine trial and develop it through phase 1 to phase 3 testing and come up with a successful evaluation about a highly efficacious vaccine during a very ...
- Lesotho Ebola simulation triggers concerns, South Africa allays fearson November 14, 2019 at 5:55 am
Reports indicated early Thursday morning that Lesotho’s health ministry mistakenly announced to the press that a woman from South Africa had been hospitalized after testing positive for Ebola. The ...
- AHF Lauds WHO's Belated Pre-Qualification of the Ebola Vaccineon November 13, 2019 at 5:21 pm
After more than four years of testing and vaccinations under compassionate use protocols, the most effective Ebola vaccine has at last received World Health Organization (WHO) pre-qualification, ...
- Five reasons healthcare data security is at Ebola crisis levelson November 13, 2019 at 4:48 am
The original intent is good - helping people deal with brain and spinal cord injuries. Testing this interface in the lab is one thing but connecting such a system to a hospital systems that use legacy ...
via Bing News